INVESTMENT MANAGEMENT TRUST AGREEMENTInvestment Management Trust Agreement • May 14th, 2021 • Lazard Healthcare Acquisition Corp. I • Blank checks • New York
This Investment Management Trust Agreement (this “Agreement”) is made effective as of [●], 2021 by and between Lazard Healthcare Acquisition Corp. I, a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”).
PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENTPrivate Placement Warrants Purchase Agreement • May 14th, 2021 • Lazard Healthcare Acquisition Corp. I • Blank checks • New York
THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT (as it may from time to time be amended, this “Agreement”), dated as of [●], 2021, is entered into by and between Lazard Healthcare Acquisition Corp. I, a Cayman Islands exempted company (the “Company”), and LHACo 1 LLC, a Delaware series limited liability company (the “Purchaser”).
Lazard Healthcare Acquisition Corp. I 25,000,000 Units Underwriting AgreementUnderwriting Agreement • May 14th, 2021 • Lazard Healthcare Acquisition Corp. I • Blank checks • New York
Lazard Healthcare Acquisition Corp. I, a Cayman Islands exempted company (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to Goldman Sachs & Co. LLC (the “Underwriter” or “you”) an aggregate of 25,000,000 units (the “Firm Units”) of the Company and, at the election of the Underwriter, up to 3,750,000 additional units, if any (the “Optional Units”; the Optional Units that the Underwriter elects to purchase pursuant to Section 2 hereof, together with the Firm Units, being collectively called the “Units”).
Lazard Healthcare Acquisition Corp. I New York, New York 10112 Re: Initial Public Offering Ladies and Gentlemen:Underwriting Agreement • May 14th, 2021 • Lazard Healthcare Acquisition Corp. I • Blank checks • New York
This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and among Lazard Healthcare Acquisition Corp. I, a Cayman Islands exempted company (the “Company”), Goldman Sachs & Co. LLC, as representative (the “Representative”) of the several underwriters (the “Underwriters”), relating to an underwritten initial public offering (the “Public Offering”) of 28,750,000 of the Company’s units (including 3,750,000 units that may be purchased pursuant to the Underwriters’ option to purchase additional units to cover over-allotments, if any) (the “Units”), each comprised of one share of the Company’s Class A ordinary shares, par value $0.0001 per share (the “Class A Ordinary Shares”), and one-fourth of one redeemable warrant. Each whole Warrant (each, a “Warrant”) entitles the holder thereof to purchase one Ordinary Share at a price of $11.50 per share, subject to adjustment. The Units will be sold i
WARRANT AGREEMENT between LAZARD HEALTHCARE ACQUISITION CORP. I and CONTINENTAL STOCK TRANSFER & TRUST COMPANY Dated [●], 2021Warrant Agreement • May 14th, 2021 • Lazard Healthcare Acquisition Corp. I • Blank checks • New York
THIS WARRANT AGREEMENT (this “Agreement”), dated [●], 2021, is by and between Lazard Healthcare Acquisition Corp. I, a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capacity, the “Warrant Agent”).
